Virbac SA
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific. The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products. I… Read more
Virbac SA (VRBCF) - Total Liabilities
Latest total liabilities as of June 2025: $750.28 Million USD
Based on the latest financial reports, Virbac SA (VRBCF) has total liabilities worth $750.28 Million USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Virbac SA - Total Liabilities Trend (2002–2024)
This chart illustrates how Virbac SA's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Virbac SA Competitors by Total Liabilities
The table below lists competitors of Virbac SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TMC the metals company Inc
NASDAQ:TMC
|
USA | $216.24 Million |
|
Kumho Petro Chemical
KO:011780
|
Korea | ₩2.19 Trillion |
|
China Conch Venture Holdings Limited
PINK:CCVTF
|
USA | $33.40 Billion |
|
Liberty Latin America Ltd Class C
NASDAQ:LILAK
|
USA | $10.89 Billion |
|
Joincare Pharmaceutical Group Industry Co Ltd
SHG:600380
|
China | CN¥11.93 Billion |
|
Pci-Suntek Technology Co Ltd
SHG:600728
|
China | CN¥7.41 Billion |
|
Beijing Xinleineng Technology Co Ltd
SHE:300593
|
China | CN¥1.81 Billion |
|
PCCOF
PINK:PCCOF
|
USA | $233.44 Billion |
Liability Composition Analysis (2002–2024)
This chart breaks down Virbac SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.96 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.70 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.41 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Virbac SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Virbac SA (2002–2024)
The table below shows the annual total liabilities of Virbac SA from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $805.12 Million | +47.51% |
| 2023-12-31 | $545.81 Million | +10.37% |
| 2022-12-31 | $494.53 Million | +3.81% |
| 2021-12-31 | $476.36 Million | +4.86% |
| 2020-12-31 | $454.28 Million | -41.11% |
| 2019-12-31 | $771.38 Million | -0.71% |
| 2018-12-31 | $776.93 Million | -2.70% |
| 2017-12-31 | $798.49 Million | -10.92% |
| 2016-12-31 | $896.37 Million | -5.47% |
| 2015-12-31 | $948.26 Million | +12.34% |
| 2014-12-31 | $844.06 Million | +75.17% |
| 2013-12-31 | $481.86 Million | +12.25% |
| 2012-12-31 | $429.28 Million | +56.23% |
| 2011-12-31 | $274.77 Million | +18.74% |
| 2010-12-31 | $231.40 Million | +16.71% |
| 2009-12-31 | $198.27 Million | -6.32% |
| 2008-12-31 | $211.64 Million | +10.03% |
| 2007-12-31 | $192.35 Million | -10.09% |
| 2006-12-31 | $213.94 Million | +38.80% |
| 2005-12-31 | $154.14 Million | -5.42% |
| 2004-12-31 | $162.96 Million | -1240.56% |
| 2003-12-31 | $-14.29 Million | +102.81% |
| 2002-12-31 | $-7.04 Million | -- |